FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 269 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $880 | -72.8% | 268 | -39.1% | 0.00% | – |
Q1 2024 | $3,230 | +62.7% | 440 | +5.5% | 0.00% | – |
Q2 2023 | $1,985 | -90.6% | 417 | -88.7% | 0.00% | -100.0% |
Q1 2023 | $21,062 | +182.4% | 3,695 | +400.0% | 0.00% | +100.0% |
Q4 2022 | $7,457 | – | 739 | +4247.1% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 17 | -50.0% | 0.00% | – |
Q2 2022 | $1,000 | -88.9% | 34 | -85.2% | 0.00% | -100.0% |
Q1 2022 | $9,000 | +350.0% | 230 | +475.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 40 | +471.4% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 7 | +16.7% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 6 | -25.0% | 0.00% | – |
Q1 2021 | $1,000 | – | 8 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |